iwCLL 2019 | The UK CLL Forum ibrutinib data: a five year follow up

Toby Eyre

Toby Eyre, MD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, discusses the UK chronic lymphocytic leukemia (CLL) forum study led by George Follows, Cambridge University Hospitals, Cambridge, UK, and the 5-year follow up data for ibrutinib in R/R CLL. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video  
Similar topics